PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsStatus epilepticus
MeSH D013226 - status epilepticus
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D012640:Seizures
$
Success rate
D013226: 
Status epilepticus
$
Success rate
D017036:Epilepsia partialis continua
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
A.H. Robins CompanyPentobarbital Pentobarbital  1982-01-01   
Acella PharmaceuticalsPhenytoin Phenytoin  2006-09-13   
AkornMidazolam Midazolam  2003-09-04   
Alembic PharmaceuticalsDiazepam Diazepam  2024-04-25   
AllerganDiazepam Diazepam  1986-02-12   
Lorazepam Lorazepam  1987-03-23   
Pentobarbital Pentobarbital  1982-01-01   
Phenytoin Phenytex  1984-12-21   
Phenytoin Phenytoin  1982-01-01   
Phenytoin Prompt Phenytoin  1982-01-01   
Propofol Propofol  2015-12-22   
Almatica PharmaLorazepam Loreev 2034-01-08 2021-08-27   
American RegentFosphenytoin Fosphenytoin  2007-08-06   
Phenytoin Phenytoin  2007-12-04   
American TherapeuticsLorazepam Lorazepam  1986-03-07   
Amneal PharmaceuticalsPhenytoin Extended Phenytoin  2008-11-12   
Fosphenytoin Fosphenytoin  2008-03-18   
Lorazepam Lorazepam  2010-06-23   
Propofol Propofol  2024-08-15   
ANDA RepositoryLorazepam Lorazepam  1991-03-29   
1
2
3
4
5
6
...
9
>
Clinical Trials
Historical Success Rate
Phase 1
100%
3/3
Phase 2
75%
9/12
Phase 3
52%
14/27
Approved: 9Overall Success rate: 39%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Aquestive Therapeutics
1
2
3
4
5
6
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use